Exposure of MCF-7 breast cancer cells (ERβ+/p53 wild type) to TSN leads to profound apoptosis, whereas T47D breast cancer cells (ERβ+/p53 L194F mutated) poorly respond to this treatment (Figure S5). The gene discussed is TP53; the disease is breast cancer.